BioSpace News Archive

GSK’s Hal Barron, former Juno Chief Executive Officer and others take on or transition into new roles. Let’s take a look at some of those!

It’s not easy to predict trends in drugs, especially with breakthroughs in immunology and genetic engineering often causing dramatic changes in how biopharma companies approach new drugs.

Regeneron Pharmaceuticals, Inc. announced that due to ongoing labeling discussions the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept)

Acerus Pharmaceuticals Corporation reported its financial results for the three months and six months ended June 30, 2018. Unless otherwise noted, all amounts are in U.S. dollars.

Express Scripts Reminds Stockholders to Vote “FOR” the Merger

Seasoned Executive Adds Significant Operational and M&A Expertise

BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug Administration’s 2018 Opioid Innovation Challenge.

A multiyear study on the adoption of speech recognition technology and its impact on provider documentation in the electronic health record software at Health Quest’s flagship hospital, Vassar Brothers Medical Center, revealed significant improvements in documentation quality, provider satisfaction, workflow, efficiency and reduced medical transcription costs.

This allows for the continued trading of the Company’s common stock on The Nasdaq Stock Market until the Panel make its determination of the Company’s appeal of the Nasdaq staff’s delisting notification.

Arizona College is proud to announce the opening of a new campus in Dallas, TX, fully dedicated to nursing education.